Compare PSA & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSA | IQV |
|---|---|---|
| Founded | 1972 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8B | 41.3B |
| IPO Year | N/A | 2013 |
| Metric | PSA | IQV |
|---|---|---|
| Price | $299.76 | $172.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $310.46 | $230.56 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 7.84 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $2.94 | $6.76 |
| Revenue Next Year | $3.44 | $5.85 |
| P/E Ratio | $33.19 | ★ $21.95 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $256.54 | $134.65 |
| 52 Week High | $312.95 | $247.05 |
| Indicator | PSA | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 40.30 |
| Support Level | $275.92 | $156.43 |
| Resistance Level | $311.39 | $193.26 |
| Average True Range (ATR) | 6.77 | 6.23 |
| MACD | -1.20 | 2.50 |
| Stochastic Oscillator | 16.58 | 53.10 |
Public Storage is the largest owner of self-storage facilities in the US, with more than 3,300 self-storage facilities in 40 states and approximately 245 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage. The company also has a merchandise business, a third-party property management business, and an insurance business that offers products to cover losses for the goods in self-storage facilities.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.